Global Extractable & Leachable Testing Services Market, By Product Tested (Container Materials/ Packaging, Single-Use, Medical Devices, Biopharmaceuticals/ Biologicals, Others), By Technique, By Region, Competition Forecast and Opportunities, 2027

The Global Extractable & Leachable Testing Services Market is Projected to Register CAGR Growth in the Forecast Years, 2023-2027, on Account of Growth Factors Like Rising Concerns Regarding Packaging and Storage of Pharmaceutical Products and Medical Devices.

The global extractable & leachable testing services market is projected to register CAGR growth in the forecast years, 2023-2027, on account of growth factors like rising concerns regarding packaging and storage of pharmaceutical products and medical devices. Increasing demands for bio-safe medical devices and the compatibility of the pharmaceutical container closure system are further driving the growth of the global extractable & leachable testing services market in the upcoming five years.

Extractables are chemical species or chemical compounds that can get extracted and mixed with the pharmaceutical product kept in the container if the container undergoes gamma radiation for any purpose. In simpler terms, the pharmaceutical containers or medical devices are sometimes made of specific toxic material that is otherwise harmless, but if the container undergoes gamma radiation for sanitization process, etc. these chemical compounds get extracted from the containers or medical devices and contaminate the pharmaceutical or disrupt the functioning of medical devices causing potential threat for later consumption. Leachable are similar compounds that leach into the pharmaceutical drug from the container closure system under normal conditions, along with the severity of the environmental conditions. Leachable does not necessarily require gamma radiations, unlike extractable. Extractables need extreme changes in the environment, like the presence of strong solvents, elevated temperatures, and gamma radiations. In comparison, leachable is released due to additives or steps during the manufacturing process, such as release agents, coatings, etc.

Expanding Pharma Industry Promises Market Growth

Rapidly growing investments and finances in the research sector drive the growth of the global extractable & leachable testing services market in the upcoming five years. Increasing instances of chronic diseases, infectious diseases, and lifestyle diseases have increased the demands for advancement in pharmaceuticals and medical devices. Although the requirement for the prolonged prescription of pharmaceuticals demands better storage and containers advancement such that post-manufacture and container toxicity could be avoided.

The governments and other authoritative bodies are actively investing in pharmaceutical development and advancing their container closure systems, thereby aiding the growth of the global extractable & leachable testing services market in the next five years. In the United States alone, over USD539 billion nominal spending on medicine was done in the year 2020. Moreover, the increasing value of the pharmaceutical industry in the world further supports the fact that further investments would substantiate the growth of the global extractable and leachable testing services market in the future five years. The global pharmaceutical industry was valued at USD1.27 trillion in the year 2020.

Market Segmentation

The global extractable & leachable testing services market segmentation is based on product tested, technique, regional distribution, and competitive landscape. Based on the product tested, the market is bifurcated into container materials/ packaging, single-use, medical devices, biopharmaceuticals/ biologicals, and others. By technique, the market is segmented into spectrometry, spectroscopy, total organic carbon, conductivity, and others. The market analysis also studies the regional segmentation, divided among the Asia-Pacific region, North American region, European region, South American region, and the Middle East & African region.

Company Profile

SGS S.A., Intertek Group plc., ALS Limited, Smithers MSE Limited, Eurofins Scientific SE, Toxikon Corp. (LabCorp), Avomeen, LLC, Sartorius AG, Pacific BioLabs Inc., Dalton Pharma Services, are enlisted in a partial list of major market players of the global extractable & leachable testing services market.

Years considered for this report:

• Historical Years: 2017-2020
• Base Year: 2021
• Estimated Year: 2022
• Forecast Period: 2023-2027

Report Scope:

In this report, global extractable & leachable testing services market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Extractable & Leachable Testing Services Market, By Product Tested:

• Container Materials/ Packaging
• Single-Use
• Medical Devices
• Biopharmaceuticals/ Biologicals
• Others

Extractable & Leachable Testing Services Market, By Technique:

• Spectrometry
• Spectroscopy
• Total Organic Carbon
• Conductivity
• Others

Extractable & Leachable Testing Services Market, By Region:

• North America
• United States
• Mexico
• Canada
• Europe
• France
• Germany
• United Kingdom
• Italy
• Spain
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• South America
• Brazil
• Argentina
• Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global extractable & leachable testing services market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.


This product will be delivered within 1-3 business days.